Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?
暂无分享,去创建一个
B. Isaksson | R. Hultcrantz | P. Stål | A. Oksanen | Per Stål | Pia Edenvik | Loa Davidsdottir | Antti Oksanen | Bengt Isaksson | Rolf Hultcrantz | P. Edenvik | L. Davidsdottir | Pia Edenvik
[1] J. Marrero,et al. Meta‐analysis: surveillance with ultrasound for early‐stage hepatocellular carcinoma in patients with cirrhosis , 2009, Alimentary pharmacology & therapeutics.
[2] Xianglin L. Du,et al. Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States , 2010, Hepatology.
[3] H. El‐Serag,et al. Utilization of screening for hepatocellular carcinoma in the United States. , 2008, Journal of clinical gastroenterology.
[4] H. El‐Serag,et al. Epidemiology of viral hepatitis and hepatocellular carcinoma. , 2012, Gastroenterology.
[5] B. Graubard,et al. Metabolic syndrome increases the risk of primary liver cancer in the United States: A study in the SEER‐medicare database , 2011, Hepatology.
[6] A. Singal,et al. Surveillance for hepatocellular carcinoma: how can we do better? , 2013, The American journal of the medical sciences.
[7] Luci K. Leykum,et al. Screening for hepatocellular carcinoma among veterans with hepatitis C on disease stage, treatment received, and survival. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[8] V. Mazzaferro,et al. EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver ⇑ , European Organisation for Research and Treatment of Cancer , 2012 .
[9] A. Singal,et al. Hepatocellular carcinoma and other liver lesions. , 2014, The Medical clinics of North America.
[10] M. Makuuchi,et al. Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version , 2011, Digestive Diseases.
[11] Zhao-You Tang,et al. Randomized controlled trial of screening for hepatocellular carcinoma , 2004, Journal of Cancer Research and Clinical Oncology.
[12] Rohit Loomba,et al. The global NAFLD epidemic , 2013, Nature Reviews Gastroenterology &Hepatology.
[13] J. Marrero,et al. Effectiveness of Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[14] Miriam B. Vos,et al. Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010. , 2013, The Journal of pediatrics.
[15] Jasmin A. Tiro,et al. Failure Rates in the Hepatocellular Carcinoma Surveillance Process , 2012, Cancer Prevention Research.
[16] Jasmin A. Tiro,et al. Practice patterns and attitudes of primary care providers and barriers to surveillance of hepatocellular carcinoma in patients with cirrhosis. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[17] J. Bruix,et al. Management of hepatocellular carcinoma: An update , 2011, Hepatology.
[18] G. Brandi,et al. Drinking habits as cofactors of risk for alcohol induced liver damage , 1997, Gut.
[19] K. Batts,et al. Chronic hepatitis. An update on terminology and reporting. , 1995, The American journal of surgical pathology.
[20] G. Hammoud,et al. Primary hepatocellular carcinoma and metabolic syndrome: An update. , 2013, World journal of gastrointestinal oncology.
[21] P. Newsome,et al. Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis , 2010, Alimentary pharmacology & therapeutics.
[22] Peter J. Richardson,et al. Hepatocellular Carcinoma Screening Practices in the Department of Veterans Affairs: Findings from a National Facility Survey , 2013, Digestive Diseases and Sciences.
[23] William M. Lee,et al. Utilization of Hepatocellular Carcinoma Surveillance Among American Patients: A Systematic Review , 2012, Journal of General Internal Medicine.
[24] B. Sangro,et al. O110 AN INTERNATIONAL COLLABORATIVE STUDY ASSESSING THE ROLE OF AETIOLOGY AND STAGE IN SURVIVAL IN HCC – IMPLICATIONS FOR SCREENING , 2014 .
[25] Jasmin A. Tiro,et al. Improving hepatocellular carcinoma screening: applying lessons from colorectal cancer screening. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[26] Amit G. Singal,et al. Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis , 2014, PLoS medicine.
[27] Steve S. Choi,et al. Risk for Hepatocellular Carcinoma in Patients With Alcoholic Cirrhosis , 2012, Annals of Internal Medicine.
[28] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[29] Rocio Lopez,et al. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis , 2010, Hepatology.
[30] J. Bruix,et al. Management of HCC. , 2012, Journal of hepatology.